
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Merck KGaA
Market Cap: €46.7b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€107.35
7D
-1.9%
1Y
-18.8%
SCHOTT Pharma KGaA
Market Cap: €2.0b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.22
7D
-2.7%
1Y
-45.0%
Bayer
Market Cap: €37.8b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€38.47
7D
-1.7%
1Y
60.3%
Evotec
Market Cap: €764.3m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.31
7D
0.1%
1Y
-33.4%
Formycon
Market Cap: €297.1m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€16.82
7D
-12.8%
1Y
-37.2%